 BIOLASE, Inc. NASDAQ: BIOL, the global leader in dental lasers, today announced the closing on June 10, 2020 of its previously announced registered direct offering of approximately 6.9 million of its common stock in a registered direct offering priced at-the-market under Nasdaq rules and warrants to purchase common stock in a concurrent private placement. The combined purchase price for one share of common stock and warrant to purchase one share of common stock was 0.64. BIOLASE intends to use the net proceeds for working capital and for other general corporate purposes. 